FDA Opens Meeting on REXULTI Drug Updates for Mental Health
Published Date: 6/17/2025
Notice
Summary
The FDA is holding a public meeting to talk about a new request for REXULTI (brexpiprazole) tablets, a medicine that helps with mental health. They want to hear from everyone before making decisions, so patients, doctors, and drug makers should pay attention. This could change how REXULTI is used and might affect treatment options soon.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in